Cardior Pharmaceuticals’ €64 Million Series B Financing Round

YPOG advised the consortium of investors on the deal, alongside with KNPZ. CMS advised Cardior Pharmaceuticals GmbH. Cardior Pharmaceuticals GmbH has closed a €64 million series B…

This content is for members only.
Login to Read More Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for members only.
Login to Read More Join Now